genOway Share Price Deutsche Boerse AG
Stocks
JEH
FR0004053510
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.290 EUR | -1.72% |
|
-2.97% | -7.66% |
| Market Cap | 2.25Cr 2.59Cr 2.09Cr 1.92Cr 3.63Cr 247.05Cr 3.69Cr 25Cr 9.69Cr 122.99Cr 9.72Cr 9.51Cr 412.41Cr | P/E 2024 * |
-
| P/E 2025 | - |
|---|---|---|---|---|---|
| Enterprise Value | 2.92Cr 3.36Cr 2.72Cr 2.5Cr 4.71Cr 320.82Cr 4.79Cr 32Cr 13Cr 159.72Cr 13Cr 12Cr 535.57Cr | EV / Sales 2024 |
1.28x | EV / Sales 2025 | 1.11x |
| Free-Float |
59.02% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -1.72% | ||
| 1 week | -2.97% | ||
| 1 month | +3.62% | ||
| 3 months | +4.09% | ||
| Current year | -7.66% |
| 1 week | 2.29 |  | 2.35 |
| 1 month | 2.11 | | 2.46 |
| Current year | 2.08 | | 2.66 |
| 1 year | 2.03 | | 3.16 |
| 3 years | 2.03 | | 4.68 |
| 5 years | 2.03 | | 4.7 |
| 10 years | 1.06 | | 6 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Chief Operating Officer | - | 01/03/1999 | |
Benjamin Bruneau
DFI | Director of Finance/CFO | - | 01/10/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 01/03/1999 | |
| Chairman | - | - | |
Laurent Fraisse
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.72% | -2.97% | - | - | 2.59Cr | |
| -1.40% | +2.59% | -1.71% | +11.28% | 4.85TCr | |
| -2.41% | -0.90% | +403.17% | +614.40% | 3.99TCr | |
| -1.16% | +12.96% | +26.45% | +5.03% | 3.87TCr | |
| -1.88% | -3.03% | +4.94% | +47.52% | 3.51TCr | |
| -1.74% | +5.12% | +9.58% | +46.02% | 2.98TCr | |
| -2.85% | -3.92% | - | - | 1.61TCr | |
| -0.21% | -4.04% | +35.09% | +127.95% | 1.61TCr | |
| -0.64% | +2.65% | +1.25% | +8.92% | 1.36TCr | |
| -1.19% | -1.32% | -3.32% | -34.94% | 1.26TCr | |
| Average | -1.52% | +1.05% | +59.43% | +103.27% | 2.78TCr | |
| Weighted average by Cap. | -1.60% | +2.03% | +76.87% | +128.10% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.75Cr 3.17Cr 2.56Cr 2.35Cr 4.44Cr 302.33Cr 4.51Cr 30Cr 12Cr 150.51Cr 12Cr 12Cr 504.7Cr | 2.86Cr 3.29Cr 2.66Cr 2.44Cr 4.62Cr 314.07Cr 4.69Cr 31Cr 12Cr 156.36Cr 12Cr 12Cr 524.3Cr |
| Net income | 18.31L 21.06L 17.04L 15.64L 29.54L 20Cr 30L 2.01Cr 78.83L 10Cr 79.09L 77.35L 34Cr | 9L 10.67L 9L 8L 14.97L 10Cr 15.2L 1.02Cr 39.95L 5.07Cr 40.08L 39.2L 17Cr |
| Net Debt | 6L 7L 6L 5L 10.05L 6.84Cr 10.21L 68.35L 26.83L 3.41Cr 26.91L 26.32L 11Cr | 67.18L 77.28L 62.53L 57.41L 1.08Cr 74Cr 1.1Cr 7.37Cr 2.89Cr 37Cr 2.9Cr 2.84Cr 123.15Cr |
Employees
157
| Date | Price | Change |
|---|---|---|
| 31/26/31 | €2.290 | -1.72% |
| 30/26/30 | €2.330 | -.--% |
| 29/26/29 | €2.330 | -0.43% |
| 28/26/28 | €2.340 | -0.43% |
| 27/26/27 | €2.350 | -0.42% |
- Stock Market
- Stocks
- ALGEN Stock
- JEH Stock
Select your edition
All financial news and data tailored to specific country editions
